搜索临床试验以：Metastatic hormone refractory prostate cancer (HRPC)
总计133509个结果
-
SanofiCanadian Urologic Oncology Group完全的
-
Novartis Pharmaceuticals终止Hormone Refractory Prostate Cancer Disease美国
-
Achieve Life SciencesTeva Pharmaceuticals USA终止激素难治性前列腺癌 | 去势抵抗性前列腺癌法国, 美国, 西班牙, 英国, 加拿大
-
Ascenta Therapeutics完全的
-
Accelerated Community Oncology Research NetworkBayer终止
-
Novartis Pharmaceuticals完全的
-
Infinity Pharmaceuticals, Inc.完全的
-
Genzyme, a Sanofi Company完全的
-
National Cancer Institute (NCI)完全的
-
University of California, San FranciscoGenzyme, a Sanofi Company完全的
-
Centocor, Inc.终止
-
Astellas Pharma IncAstellas Pharma US, Inc.完全的
-
Astellas Pharma Inc完全的
-
The Methodist Hospital Research InstituteOxford BioMedica终止
-
Bostwick LaboratoriesProstate Institute of America; Community Memorial HealthCenter; HemaCare Corporation终止